Baba, Hayato
Oba, Atsushi
Tanaka, Kimitaka
Miura, Takayuki
Ban, Daisuke
Edanami, Motonori
Ishikawa, Yoshiya
Ohgi, Katsuhisa
Tanaka, Haruyoshi
Shintakuya, Ryuta
Ikenaga, Naoki
Ijichi, Tetsuya
Kiya, Yoshitaka
Muranushi, Ryo
Yamaki, So
Miyazaki, Naoki
Takeuchi, Shintaro
Aoki, Shuichi
Mizui, Takahiro
Tanaka, Masayuki
Ueda, Hiroki
Dei, Hideyuki
Takami, Hideki
Okada, Kenjiro
Nakata, Kohei
Mataki, Yuko
Osakabe, Hiroaki
Shibuya, Kazuto
Hashimoto, Daisuke
Inoue, Yosuke
Hirano, Satoshi
Unno, Michiaki
Esaki, Minoru
Kitago, Minoru
Akahoshi, Keiichi
Sugiura, Teiichi
Ebata, Tomoki
Uemura, Kenichiro
Nakamura, Masafumi
Otsuka, Takao
Nagakawa, Yuichi
Fujii, Tsutomu
Satoi, Sohei
Takahashi, Yu
Article History
Received: 4 September 2024
Accepted: 3 October 2024
First Online: 16 October 2024
Declarations
:
: Ethical approval was granted by the Certified Review Board of Cancer Institute Hospital of Japanese Foundation for Cancer Research. The Patients provided their written informed consent to participate in this trial.
: Not applicable.
: Atsushi Oba has been awarded a grant (Bayer Yakuhin, Ltd.) to conduct an observational study to investigate the clinical impact of EOB-MRI. The other authors have no conflicts of interest to declare. Sohei Satoi declared research fundings from Nihon Servier, Amino-up co. and Boston Scientific.